Insider trades
Cormorant Private Healthcare Fund IV, 10% Owner of MoonLake Immunotherapeutics MLTX, has filed 5 purchases and 7 sales on the open market. The latest trade was on 25/09/30.
Cormorant Private Healthcare Fund IV
Former 10% Owner
- First filing
- 23/10/10
- Trades
- 14 trades
- Buys / sales
- 5 / 7
- 12-month net buying
- No record
- Last trade
- 25/09/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MLTX | Open-market sale | 25/09/29–25/09/30 | 25/10/01 | 6,499,978 sh5 trades | $7.21avg. | $46,868,184.1 | −76.5% |
| Open-market sale | 25/05/15 | 25/05/19 | 1,813,439 sh | $1.85 | $3,354,862.15 | −100.0% | |
| Open-market sale | 25/05/12 | 25/05/14 | 24,300 sh | $1.99 | $48,357 | −1.3% | |
BioAge LabsBIOA | Open-market buy | 24/09/27 | 24/10/01 | 450,000 sh | $18.00 | $8,100,000 | +38.2% |
| Open-market buy | 23/10/05 | 23/10/10 | 58,839 sh | $59.90 | $3,524,456.1 | +0.7% | |
MLTX | Open-market buy | 23/10/02–23/10/04 | 23/10/04 | 293,212 sh3 trades | $57.30avg. | $16,800,123.3 | +3.6% |
